Liang, I.-C.; Chang, H.-H.; Lai, Y.-J.; Chan, C.-M.; Sung, C.-H.; Pu, C.-M.; Chang, D.-C.; Ho, C.-C.; Hung, C.-F.
Update on the Efficacy and Safety of Sodium–Glucose Co-Transporter 2 Inhibitors in Patients with Chronic Diseases: A Systematic Review and Meta-Analysis. Medicina 2025, 61, 202.
https://doi.org/10.3390/medicina61020202
AMA Style
Liang I-C, Chang H-H, Lai Y-J, Chan C-M, Sung C-H, Pu C-M, Chang D-C, Ho C-C, Hung C-F.
Update on the Efficacy and Safety of Sodium–Glucose Co-Transporter 2 Inhibitors in Patients with Chronic Diseases: A Systematic Review and Meta-Analysis. Medicina. 2025; 61(2):202.
https://doi.org/10.3390/medicina61020202
Chicago/Turabian Style
Liang, I-Chia, Hsun-Hao Chang, Yu-Jou Lai, Chi-Ming Chan, Chao-Hsien Sung, Chi-Ming Pu, Der-Chen Chang, Ching-Chih Ho, and Chi-Feng Hung.
2025. "Update on the Efficacy and Safety of Sodium–Glucose Co-Transporter 2 Inhibitors in Patients with Chronic Diseases: A Systematic Review and Meta-Analysis" Medicina 61, no. 2: 202.
https://doi.org/10.3390/medicina61020202
APA Style
Liang, I.-C., Chang, H.-H., Lai, Y.-J., Chan, C.-M., Sung, C.-H., Pu, C.-M., Chang, D.-C., Ho, C.-C., & Hung, C.-F.
(2025). Update on the Efficacy and Safety of Sodium–Glucose Co-Transporter 2 Inhibitors in Patients with Chronic Diseases: A Systematic Review and Meta-Analysis. Medicina, 61(2), 202.
https://doi.org/10.3390/medicina61020202
